EP 1218025 A4 20050601 - USE OF MULLERIAN INHIBITING SUBSTANCE FOR TREATING EXCESS ANDROGEN STATES
Title (en)
USE OF MULLERIAN INHIBITING SUBSTANCE FOR TREATING EXCESS ANDROGEN STATES
Title (de)
VERWENDUNG VON MÜLLERSCHER INHIBIERENDER SUBSTANZ ZUR BEHANDLUNG VON ANDROGENÜBERSCHUSS ZUSTÄNDEN
Title (fr)
UTILISATION DE LA SUBSTANCE D'INHIBITION DES CANAUX DE MULLER POUR LE TRAITEMENT DES ETATS PATHOLOGIQUES CARACTERISES PAR UN EXCES D'ANDROGENES
Publication
Application
Priority
- US 0025094 W 20000914
- US 15367499 P 19990914
- US 15394099 P 19990915
Abstract (en)
[origin: WO0119387A1] The present invention provides a method of treating a condition or disease characterized by an excess of one or more androgens, the method comprising administering an effective amount of MIS protein or nucleic acid encoding MIS to a patient. The present invention also provides a method of decreasing the level of one or more androgens to a level below the normal level, the method comprising administering an effective amount of MIS protein or nucleic acid encoding MIS to a patient. The methods of the present invention are particularly well-suited for the treatment of prostatic cancer, polycystic ovarian disease, benign prostatic hypertrophy, and precocious puberty.
IPC 1-7
IPC 8 full level
A61K 48/00 (2006.01); A61K 31/7088 (2006.01); A61K 35/76 (2006.01); A61K 38/22 (2006.01); A61P 5/28 (2006.01); A61P 13/08 (2006.01); A61P 15/00 (2006.01); A61P 15/08 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP)
A61K 38/22 (2013.01); A61P 5/28 (2017.12); A61P 13/08 (2017.12); A61P 15/00 (2017.12); A61P 15/08 (2017.12); A61P 35/00 (2017.12); A61K 48/00 (2013.01)
Citation (search report)
- No further relevant documents disclosed
- See references of WO 0119387A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0119387 A1 20010322; AU 7483000 A 20010417; CA 2384991 A1 20010322; EP 1218025 A1 20020703; EP 1218025 A4 20050601; JP 2003509377 A 20030311
DOCDB simple family (application)
US 0025094 W 20000914; AU 7483000 A 20000914; CA 2384991 A 20000914; EP 00963414 A 20000914; JP 2001523019 A 20000914